1. Home
  2. IBRX vs BZ Comparison

IBRX vs BZ Comparison

Compare IBRX & BZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.54

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

BZ

KANZHUN LIMITED American Depository Shares

HOLD

Current Price

$15.36

Market Cap

6.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
BZ
Founded
2014
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.1B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
IBRX
BZ
Price
$7.54
$15.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$12.57
$23.00
AVG Volume (30 Days)
12.2M
3.1M
Earning Date
05-08-2026
05-21-2026
Dividend Yield
N/A
1.24%
EPS Growth
38.71
N/A
EPS
N/A
N/A
Revenue
$113,288,000.00
N/A
Revenue This Year
$88.59
$15.92
Revenue Next Year
$131.15
$12.78
P/E Ratio
N/A
$22.61
Revenue Growth
668.31
N/A
52 Week Low
$1.95
$12.56
52 Week High
$12.43
$25.26

Technical Indicators

Market Signals
Indicator
IBRX
BZ
Relative Strength Index (RSI) 44.85 61.55
Support Level $6.69 $12.95
Resistance Level $8.54 $21.60
Average True Range (ATR) 0.54 0.52
MACD -0.12 0.20
Stochastic Oscillator 12.61 81.96

Price Performance

Historical Comparison
IBRX
BZ

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About BZ KANZHUN LIMITED American Depository Shares

Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.

Share on Social Networks: